NCT06370156View on ClinicalTrials.gov

Evaluation of TWEAK in Plaque Psoriasis and Psoriatic Arthritis Patients

Not yet recruitingOBSERVATIONAL

Enrollment

100

Participants

Timeline

Start Date

June 1, 2024

Primary Completion Date

June 1, 2025

Study Completion Date

June 10, 2025

Conditions

Plaque Psoriasis

Interventions

DRUG

Adalimumab

To suggests the role of TWEAK and the effectiveness of different treatments like adalimumab and methotrexate in managing plaque psoriasis and psoriatic arthritis.

Trial Locations (1)

Unknown

South Valley Hospitals, Qina

All Listed Sponsors

lead

Egymedicalpedia

INDUSTRY

NCT06370156 - Evaluation of TWEAK in Plaque Psoriasis and Psoriatic Arthritis Patients | Biotech Hunter | Biotech Hunter